title: Acute inflammatory response secondary to intrapleural administration of two types of talc.
abstract: Intrapleural instillation of talc has been used in the treatment of recurrent pleural effusions but can, in rare instances, result in respiratory failure. Side-effects seem to be related to composition, size and inflammatory power of talc particles. The aim of this study was to evaluate the inflammatory response to intrapleural injection of talc containing small particles (ST) or talc containing particles of mixed size (MT). 100 rabbits received intrapleural talc, 50 with ST (median 6.41 mum) and 50 with MT (median 21.15 mum); the control group was composed of 35 rabbits. Cells, lactate dehydrogenase, C-reactive protein (CRP), interleukin (IL)-8 and vascular endothelial growth factor were evaluated in serum and bronchoalveolar lavage at 6, 24, 48, 72 and 96 h. Lung histology and the presence of talc were also analysed. Statistics were performed using ANOVA and an unpaired t-test. Most of the parameters showed greater levels in the animals injected with talc than in the controls, suggesting a systemic and pulmonary response. Higher serum levels of CRP and IL-8 were observed in the animals injected with ST. Talc particles were observed in both lungs with no differences between groups. Lung cell infiltrate was more evident in the ST group. In conclusion, talc with larger particles should be the preferred choice in clinical practice in order to induce safer pleurodesis.
authors.affiliation: R Itapeva 500, cjto 4C, Bela Vista, São Paulo, 01332-000, Brazil.
authors.forename: V F
authors.initials: VF
authors.lastname: Rossi
authors.forename: F S
authors.initials: FS
authors.lastname: Vargas
authors.forename: E
authors.initials: E
authors.lastname: Marchi
authors.forename: M M P
authors.initials: MM
authors.lastname: Acencio
authors.forename: E H
authors.initials: EH
authors.lastname: Genofre
authors.forename: V L
authors.initials: VL
authors.lastname: Capelozzi
authors.forename: L
authors.initials: L
authors.lastname: Antonangelo
mesh_terms: D000818:Animals; D002097:C-Reactive Protein / Q000096:biosynthesis; D007249:Inflammation; D016209:Interleukin-8 / Q000097:blood; D007770:L-Lactate Dehydrogenase / Q000097:blood; D010316:Particle Size; D010994:Pleura / Q000187:drug effects* / Q000473:pathology; D018700:Pleurodesis / Q000009:adverse effects / Q000379:methods*; D011817:Rabbits; D013627:Talc / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000097:blood
chemical_list: D016209:Interleukin-8; D042461:Vascular Endothelial Growth Factor A; D013627:Talc; D002097:C-Reactive Protein; D007770:L-Lactate Dehydrogenase